| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/02/1997 | CN1153477A Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
| 07/02/1997 | CN1153474A Stable oil-in-water emulsions incorporating taxine (taxol) and method of making same |
| 07/02/1997 | CN1153473A Use of droloxifene for treatment of cardiovascular diseases |
| 07/02/1997 | CN1153176A Stable crystalline tetrahydrofolic acid salts |
| 07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643959 Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof |
| 07/01/1997 | US5643909 10,11-Methanodibenzosuberane derivatives |
| 07/01/1997 | US5643908 Collagenase inhibitor |
| 07/01/1997 | US5643885 Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment |
| 07/01/1997 | US5643884 Antiinflammatory agents |
| 07/01/1997 | US5643871 Antitumor antibiotics |
| 07/01/1997 | US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
| 07/01/1997 | US5643788 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 07/01/1997 | US5643759 Hybridoma cell lines |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
| 07/01/1997 | US5643578 Subunit vaccines |
| 07/01/1997 | US5643575 Non-antigenic branched polymer conjugates |
| 07/01/1997 | US5643567 Antigrowth agents for tumors |
| 06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022621A2 Antineoplastic peptides |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments |
| 06/26/1997 | WO1997022596A1 Quinazoline derivatives |
| 06/26/1997 | WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 06/26/1997 | WO1997022360A2 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997018816A3 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells |
| 06/26/1997 | DE19548708A1 Cyclische Sulfone Cyclic sulfones |
| 06/26/1997 | DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | DE19548114A1 Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether A conjugate comprising an active substance, a polypeptide and a polyether |
| 06/26/1997 | CA2241080A1 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
| 06/25/1997 | EP0780397A2 New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/25/1997 | EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | EP0641358A4 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR. |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
| 06/25/1997 | CN1152924A Proteins from mammaliam liver and their use in oncology |
| 06/25/1997 | CN1152879A Conjugates made of metal complexes and oligonucleotides |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases |
| 06/25/1997 | CN1152464A Health care tea for anti-tumour |
| 06/25/1997 | CN1152463A Powder medicine for tumour |
| 06/25/1997 | CN1152446A Pill medicine for cancer and preparation method |
| 06/25/1997 | CN1035257C Midified plutelet factor-4 |
| 06/25/1997 | CN1035255C Heterotricyclic derivatives |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641814 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 06/24/1997 | US5641803 Injecting regulated dosages over a shorter time period causes less myelosuppression and hematologic toxicity |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641774 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641771 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641757 Stable 2-chloro-2'-deoxyadenosine formulations |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641471 Method for preparing 213 Bi for therapeutic use |
| 06/22/1997 | CA2193610A1 17 .alpha.-cyanomethylestra-4, 9-dien derivative compounds, processes for making same and pharmaceutical compositions containing same |
| 06/19/1997 | WO1997021808A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021701A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997016221A3 Genetic induction of receptors for targeted radiotherapy |
| 06/19/1997 | WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 06/19/1997 | WO1997010796A3 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |